Ionic Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Ionic Capital Management’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-75,172	Closed	-$16.5K	–	253
2023 Q3	$16.5K	Sell	75,172 -159,741	-68%	-$29.2K	﹤0.01%	198
2023 Q2	$28K	Hold	234,913	–	–	0.01%	196
2023 Q1	$11.6K	Hold	234,913	–	–	﹤0.01%	285
2022 Q4	$54.9K	Hold	234,913	–	–	0.01%	238
2022 Q3	$13K	Hold	234,913	–	–	﹤0.01%	435
2022 Q2	$21K	Hold	234,913	–	–	﹤0.01%	410
2022 Q1	$85K	Buy	+234,913	New	+$104K	0.01%	368

Other funds holding CLDI.WS

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Ionic Capital Management's CLDI.WS Position: Q4 2023 in Review

Ionic Capital Management sold out of Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 (CLDI.WS) in Q4 2023, closing a stake of 75,172 shares — an estimated $16.5K sold.

Ionic Capital Management first reported a position in CLDI.WS in Q1 2022 and held it in 7 quarters. The position peaked at $85K in Q1 2022. 17 funds tracked by Wall St. Rank hold CLDI.WS as of Q4 2023.

Ionic Capital Management reported no remaining Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position as of Q4 2023 after selling out during the quarter.
Ionic Capital Management sold 75,172 Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 shares in Q4 2023, an estimated $16.5K.
Ionic Capital Management first reported a position in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in Q1 2022 and held it in 7 quarters.
Ionic Capital Management's Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position peaked at $85K in Q1 2022.
17 funds tracked by Wall St. Rank held Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 as of Q4 2023.

Based on Ionic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.